These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 19922532)

  • 1. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus.
    Saha M; Powell AM; Bhogal B; Black MM; Groves RW
    Br J Dermatol; 2010 Apr; 162(4):790-7. PubMed ID: 19922532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
    Mahajan VK; Sharma NL; Sharma RC; Garg G
    Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption.
    Shimanovich I; Herzog S; Schmidt E; Opitz A; Klinker E; Bröcker EB; Goebeler M; Zillikens D
    Clin Exp Dermatol; 2006 Nov; 31(6):768-74. PubMed ID: 16824051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris.
    Shahidi-Dadras M; Karami A; Toosy P; Shafiyan A
    Arch Iran Med; 2007 Jan; 10(1):1-6. PubMed ID: 17198445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone-cyclophosphamide pulse therapy in pemphigus: a review of 72 cases.
    Zivanovic D; Medenica L; Tanasilovic S; Vesic S; Skiljevic D; Tomovic M; Nikolic MM
    Am J Clin Dermatol; 2010; 11(2):123-9. PubMed ID: 20141233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
    Mentink LF; Mackenzie MW; Tóth GG; Laseur M; Lambert FP; Veeger NJ; Cianchini G; Pavlovic MD; Jonkman MF
    Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus.
    Sami N; Qureshi A; Ahmed AR
    Eur J Dermatol; 2002; 12(2):174-8. PubMed ID: 11872417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Luger TA
    Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris.
    Sharma VK; Khandpur S
    Clin Exp Dermatol; 2013 Aug; 38(6):659-64. PubMed ID: 23837939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oropharyngeal pemphigus vulgaris and clinical remission: a long-term, longitudinal study.
    Mignogna MD; Fortuna G; Leuci S; Ruoppo E
    Am J Clin Dermatol; 2010; 11(2):137-45. PubMed ID: 20141235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment.
    Ahmed AR
    J Am Acad Dermatol; 2001 Nov; 45(5):679-90. PubMed ID: 11606916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris.
    Euler HH; Löffler H; Christophers E
    Arch Dermatol; 1987 Sep; 123(9):1205-10. PubMed ID: 3632005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
    España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A
    Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold: an old drug still working in refractory pemphigus.
    Iranzo P; Alsina MM; Martínez-De Pablo I; Segura S; Mascaró JM; Herrero C
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):902-7. PubMed ID: 17658998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide pulses with oral prednisolone in the treatment of pemphigus: a pilot study.
    Bhat R; Sharma VK; Ramam M; Kumar A
    Dermatol Online J; 2005 Dec; 11(3):4. PubMed ID: 16409900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two courses of rituximab (anti-CD20 monoclonal antibody) for recalcitrant pemphigus vulgaris.
    Faurschou A; Gniadecki R
    Int J Dermatol; 2008 Mar; 47(3):292-4. PubMed ID: 18289336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
    Kim MR; Kim HC; Kim SC
    Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.